- Home
- OCEAW vs REGCP Comparison
OCEAW vs REGCP Comparison
Compare OCEAW & REGCP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OCEAW
- REGCP
- Stock Information
- Founded
- OCEAW N/A
- REGCP N/A
- Country
- OCEAW United States
- REGCP United States
- Employees
- OCEAW 7
- REGCP 497
- Industry
- OCEAW Biotechnology: Pharmaceutical Preparations
- REGCP
- Sector
- OCEAW Health Care
- REGCP
- Exchange
- OCEAW Nasdaq
- REGCP Nasdaq
- Market Cap
- OCEAW N/A
- REGCP N/A
- IPO Year
- OCEAW 2021
- REGCP N/A
- Fundamental
- Price
- OCEAW $0.03
- REGCP $23.58
- Analyst Decision
- OCEAW
- REGCP
- Analyst Count
- OCEAW 0
- REGCP 0
- Target Price
- OCEAW N/A
- REGCP N/A
- AVG Volume (30 Days)
- OCEAW N/A
- REGCP N/A
- Earning Date
- OCEAW N/A
- REGCP N/A
- Dividend Yield
- OCEAW N/A
- REGCP N/A
- EPS Growth
- OCEAW N/A
- REGCP N/A
- EPS
- OCEAW N/A
- REGCP N/A
- Revenue
- OCEAW N/A
- REGCP N/A
- Revenue This Year
- OCEAW N/A
- REGCP N/A
- Revenue Next Year
- OCEAW N/A
- REGCP N/A
- P/E Ratio
- OCEAW N/A
- REGCP N/A
- Revenue Growth
- OCEAW N/A
- REGCP N/A
- 52 Week Low
- OCEAW N/A
- REGCP N/A
- 52 Week High
- OCEAW N/A
- REGCP N/A
- Technical
- Relative Strength Index (RSI)
- OCEAW N/A
- REGCP 49.45
- Support Level
- OCEAW N/A
- REGCP $23.50
- Resistance Level
- OCEAW N/A
- REGCP $23.71
- Average True Range (ATR)
- OCEAW 0.00
- REGCP 0.19
- MACD
- OCEAW 0.00
- REGCP 0.03
- Stochastic Oscillator
- OCEAW 0.00
- REGCP 51.85
About OCEAW Ocean Biomediacal Inc.
Ocean Biomedical Inc is a biopharmaceutical company that is focused on discovering and developing therapeutic products in oncology, fibrosis, and infectious diseases. The company is developing an antibody therapeutic product candidate inhibiting Chi3l1, and a bi-specific antibody product candidate inhibiting Chi3l1 plus PD-1 and CTLA-4 for the treatment of non-small cell lung cancer and glioblastoma multiforme; and a small molecule product candidate targeting Chit1 for the treatment of Idiopathic Pulmonary Fibrosis and Hermansky-Pudlak Syndrome.
About REGCP Regency Centers Corporation
Regency Centers is one of the largest shopping center-focused retail REITs. The company's portfolio includes an interest in 483 properties, which includes over 57 million square feet of retail space following the completion of the Urstadt Biddle acquisition in August 2023. The portfolio is geographically diversified with 22 regional offices and no single market representing more than 12% of total company net operating income. Regency's retail portfolio is primarily composed of grocery-anchored centers, with 80% of properties featuring a grocery anchor and grocery stores representing 20% of annual base rent.